Plasma renin and angiotensin II measurement in hypertensive and normal subjects: correlation of basal and stimulated states. 1977

J D Swales, and H Thurston

Plasma renin activity (PRA) and angiotensin II (AII) were measured in peripheral venous samples obtained from the following subgroups: normal ambulant subjects (n = 61): normal subjects after 7 days treatment with a thiazide diuretic (n = 27): hypertensive subjects before and after a thiazide diruretic (n = 35); severely hypertensive subjects after diazoxide treatment (n = 14) and untreated severely hypertensive subjects (n = 27). In addition aortic (n = 27) and renal vein (n =48) samples were taken from the latter group during investigation of possible renovascular hypertension. Values for PRA and AII were clearly correlated in all groups. Further, calculated regression lines of PRA upon AII did not differ significantly from that calculated for normal subjects, with the exception of the intercept of the diazoxide treated group. However, when the regression line for renal venous samples was compared with that calculated for peripheral venous samples of all other subjects (199), there was a relative increase in the ratio of PRA to AII at all values. Thus, except in the renal vein, measurement of AII and PRA appear to reflect changes in activity of the renin-angiotensin system equally well and there is no support for the view that there is a discrepancy between measured AII and PRA in peripheral venous blood in the clinical situations examined here.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D003981 Diazoxide A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. Hyperstat,Proglycem
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

J D Swales, and H Thurston
November 1968, The Journal of clinical endocrinology and metabolism,
J D Swales, and H Thurston
February 1973, Lancet (London, England),
J D Swales, and H Thurston
March 1969, British medical journal,
J D Swales, and H Thurston
January 1978, Annales de medecine interne,
J D Swales, and H Thurston
December 1976, Clinical science and molecular medicine. Supplement,
J D Swales, and H Thurston
March 2001, Journal of the renin-angiotensin-aldosterone system : JRAAS,
Copied contents to your clipboard!